Back to Search
Start Over
Allied to invest in Seelze facility as part of pharma development plan.
- Source :
- Chemical Market Reporter; 03/16/98, Vol. 253 Issue 11, p1, 1/6p
- Publication Year :
- 1998
-
Abstract
- Focuses on plans for the expansion of the cyclic guanosime monophosphate (cGMP) development capability of the pharmaceutical intermediates facility of AlliedSignal Inc.'s specialty chemicals business in Seelze, Germany. Highlights of the multi-million dollar expansion; Rationale behind the expansion; Acquisition of the Iropharm Ltd. as part of the expansion thrust.
- Subjects :
- DRUG factories
Subjects
Details
- Language :
- English
- ISSN :
- 10920110
- Volume :
- 253
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Chemical Market Reporter
- Publication Type :
- Periodical
- Accession number :
- 380770